Abstract:Background: The prevalence of diabetes is predicted to rise significantly in the coming decades. A recent analysis projects that by the year 2030 there will be ~366 million diabetics around the world, leading to an increased demand for inexpensive insulin to make this life-saving drug also affordable for resource poor countries. Results: A synthetic insulin precursor (IP)-encoding gene, codon-optimized for expression in P. pastoris, was cloned in frame with the Saccharomyces cerevisiae alpha-factor secretory signal and integrated into the genome of P. pastoris strain X-33. The strain was grown to high-cell density in a batch procedure using a defined medium with low salt and high glycerol concentrations. Following batch growth, production of IP was carried out at methanol concentrations of 2 g L-1, which were kept constant throughout the remaining production phase. This robust feeding strategy led to the secretion of approximately 3 gram IP per liter of culture broth (corresponding to almost 4 gram IP per liter of cell-free culture supernatant). Using immobilized metal ion affinity chromatography (IMAC) as a novel approach for IP purification, 95% of the secreted product was recovered with a purity of 96% from the clarified culture supernatant. Finally, the purified IP was trypsin digested, transpeptidated, deprotected and further purified leading to approximately 1.5 g of 99% pure recombinant human insulin per liter of culture broth. Conclusions: A simple two-phase cultivation process composed of a glycerol batch and a constant methanol fed-batch phase recently developed for the intracellular production of the Hepatitis B surface antigen was adapted to secretory IP production. Compared to the highest previously reported value, this approach resulted in an ~2 fold enhancement of IP production using Pichia based expression systems, thus significantly increasing the efficiency of insulin manufacture.

Functional expression of recombinant insulins in Saccharomyces cerevisiae

Progress in Recombinant Construction of Saccharomyces cerevisiae for Improving Ethanol Production

Cell factories for insulin production

Production of recombinant human insulin from a promising Pseudomonas fluorescens cell factory and its kinetic modeling

Insulin and Its Single-Chain Analogue

Application of simple fed-batch technique to high-level secretory production of insulin precursor using Pichia pastoris with subsequent purification and conversion to human insulin

Construction Of A Glucose And Xylose Co-Fermenting Industrial Saccharomyces Cerevisiae By Expression Of Codon-Optimized Fungal Xylose Isomerase

Cloning, Expression, and Purification of Recombinant Human-Insulin Analogue Gene in E.coli

Studies of the Growth Kinetics and Induction Strategy with a Strain of Recombinant Yeast Pichia Pastoris Expressing the Human Insulin Gene

RSM optimization of HSA/IL1Ra in Pichia pastoris overexpression strain and study of its in vivo activity in reducing hyperglycemia of GK rats.

Exploring the Potential of Saccharomyces Cerevisiae for Biopharmaceutical Protein Production

Expression and purification of recombinant human insulin from E. coli 20 strain

Soluble insulin analogs combining rapid- and long-acting hypoglycemic properties – From an efficient E. coli expression system to a pharmaceutical formulation

Biopharmaceutical Protein Production by Saccharomyces Cerevisiae: Current State and Future Prospects

Improved Production of a Heterologous Amylase in Saccharomyces Cerevisiae by Inverse Metabolic Engineering

Mature Insulin Production by Engineered Non-Beta Cells.

Inverse metabolic engineering for improving protein content in Saccharomyces cerevisiae

Metabolic switching, growth kinetics and cell yields in the scalable manufacture of stem cell-derived insulin-producing cells

A Simple Unstructured Model-Based Control for Efficient Expression of Recombinant Porcine Insulin Precursor by Pichia Pastoris

Separation and Purification of Recombinant Human Insulin and C Peptide Expressed in the Yeast Pichia Pastoris

Engineering the protein secretory pathway of Saccharomyces cerevisiae enables improved protein production.